Bulletin
Investor Alert

Cerecor Inc.

NAS: CERC

GO
/marketstate/country/us

After Hours

 --Quotes are delayed by 20 min

Aug 11, 2020, 7:59 p.m.

/zigman2/quotes/201368871/composite

$

2.92

Change

+0.15 +5.42%

Volume

Volume 4,817

Quotes are delayed by 20 min

/zigman2/quotes/201368871/composite

Today's close

$ 2.86

$ 2.77

Change

-0.09 -3.15%

Day low

Day high

$2.74

$2.92

Open

52 week low

52 week high

$1.52

$6.19

Open

Garry Arthur Neil

Garry Arthur Neil holds the position of Chief Medical Officer of Cerecor, Inc. He is also Principal at The FDA Alliance, Member of BioMarker Pharmaceuticals, Inc. and Principal at American College of Gastroenterology and on the board of 6 other companies.

In the past Dr. Neil held the position of Vice President-Research & Development at Merck KGaA and Vice President-Research & Development of EMD Pharmaceuticals, Inc. (a subsidiary of Merck KGaA), Vice President-Science & Technology at Johnson & Johnson and Group President at Johnson & Johnson Pharmaceutical Research & Development LLC (a subsidiary of Johnson & Johnson), Principal at Astra LLC, Member of Bard's Tale Beer Co. LLC, Partner at Apple Tree Partners, Chief Scientific Officer at Aevi Genomic Medicine, Inc., Vice President-Clinical Research at Astra Merck, Inc., Vice President-Clinical Research at AstraZeneca LP, Principal at American College of Physicians, Inc., Principal at Astra Pharmaceuticals LP, Chairman for Pharmaceutical Research & Manufacturers Association, Chairman of PhRMA Foundation, Chairman at Transcelerate Biopharma, Inc., Principal at the University of Iowa, Principal at the University of Toronto, Principal at the University of Pennsylvania, Principal at Ludwig Institute for Cancer Research Ltd. and Chairman at Pharmaceutical Research & Manufacturers of America.

Garry Arthur Neil received an undergraduate degree from the University of Saskatchewan and a doctorate from the University of Saskatchewan College of Medicine.

Transactions

Date Shares Transaction Value
06/10/2020 1,799   Acquisition at $2.28 per share. 4,101
02/03/2020 72,282   Award at $0 per share. 0

Officers and Executives

Mr. Michael F. Cola
Chief Executive Officer & Director
Mr. Christopher Sullivan
Chief Financial & Accounting Officer
Dr. Garry Arthur Neil
Chief Medical Officer
Dr. H. Jeffrey Wilkins
Chief Development Officer
Dr. Bernadine Heather Fraser
VP-Clinical Operations & Project Management
Mr. Joseph M. Miller
Director
Mr. James A. Harrell
Chief Commercial Officer
Dr. Sol J. Barer
Chairman
Dr. Suzanne Louise Bruhn
Independent Director
Dr. Gunnar Magnus Modee Persson
Independent Director
Mr. Phil Gutry
Independent Director
Mr. Steven Joseph Boyd
Independent Director
Link to MarketWatch's Slice.